n | CK18 Immunostaining | p | ||||
---|---|---|---|---|---|---|
Negative (%) | Weak (%) | Moderate (%) | Strong (%) | |||
Invasive breast carcinoma of no special type | ||||||
All cancers | 935 | 3.6 | 22.2 | 23.9 | 50.3 | |
pT1 | 497 | 4.2 | 18.9 | 25.0 | 51.9 | 0.0611 |
pT2 | 333 | 2.4 | 26.1 | 23.7 | 47.8 | |
pT3-4 | 73 | 6.9 | 19.2 | 16.4 | 57.5 | |
Grade 1 | 147 | 0.0 | 16.3 | 21.1 | 62.6 | < 0.0001 |
Grade 2 | 479 | 2.1 | 19.0 | 26.7 | 52.2 | |
Grade 3 | 308 | 7.8 | 30.2 | 20.5 | 41.6 | |
pN0 | 439 | 3.2 | 20.1 | 23.9 | 52.9 | 0.6092 |
pN+ | 299 | 2.7 | 23.1 | 25.8 | 48.5 | |
HER2 negative | 697 | 4.0 | 20.8 | 22.0 | 53.2 | 0.1689 |
HER2 positive | 89 | 1.1 | 18.0 | 30.3 | 50.6 | |
ER negative | 160 | 15.0 | 33.8 | 23.1 | 28.1 | < 0.0001 |
ER positive | 589 | 0.5 | 16.6 | 22.8 | 60.1 | |
PR negative | 308 | 8.8 | 28.6 | 24.0 | 38.6 | < 0.0001 |
PR positive | 472 | 0.4 | 15.7 | 22.7 | 61.2 | |
Non-triple negative | 619 | 0.8 | 17.5 | 22.5 | 59.3 | < 0.0001 |
Triple negative | 107 | 20.6 | 37.4 | 21.5 | 20.6 | |
Clear cell renal cell carcinoma | ||||||
All cancers | 674 | 48.7 | 30.4 | 14.1 | 6.8 | |
ISUP 1 | 217 | 42.9 | 35.5 | 15.2 | 6.5 | 0.1312 |
ISUP 2 | 218 | 50.5 | 28.4 | 13.8 | 7.3 | |
ISUP 3 | 189 | 51.3 | 30.2 | 13.2 | 5.3 | |
ISUP 4 | 40 | 67.5 | 17.5 | 5.0 | 10.0 | |
Fuhrmann 1 | 32 | 37.5 | 34.4 | 21.9 | 6.3 | 0.2311 |
Fuhrmann 2 | 399 | 46.4 | 31.6 | 15.0 | 7.0 | |
Fuhrmann 3 | 194 | 52.1 | 30.9 | 11.3 | 5.7 | |
Fuhrmann 4 | 48 | 62.5 | 16.7 | 10.4 | 10.4 | |
Thoenes 1 | 239 | 41.0 | 33.9 | 17.6 | 7.5 | 0.0086 |
Thoenes 2 | 369 | 51.8 | 30.1 | 12.7 | 5.4 | |
Thoenes 3 | 65 | 60.0 | 20.0 | 7.7 | 12.3 | |
UICC 1 | 294 | 37.4 | 36.1 | 19.0 | 7.5 | 0.0010 |
UICC 2 | 34 | 50.0 | 32.4 | 11.8 | 5.9 | |
UICC 3 | 87 | 58.6 | 20.7 | 11.5 | 9.2 | |
UICC 4 | 70 | 57.1 | 34.3 | 7.1 | 1.4 | |
pT1 | 391 | 40.2 | 35.8 | 16.1 | 7.9 | < 0.0001 |
pT2 | 72 | 59.7 | 25.0 | 11.1 | 4.2 | |
pT3 | 206 | 61.7 | 21.4 | 11.2 | 5.8 | |
pN0 | 114 | 55.3 | 28.9 | 7.9 | 7.9 | 0.5327 |
pN+ | 16 | 43.8 | 25.0 | 18.8 | 12.5 | |
pM0 | 102 | 39.2 | 35.3 | 15.7 | 9.8 | < 0.0001 |
pM + | 73 | 64.4 | 31.5 | 4.1 | 0.0 | |
Urinary bladder cancer | ||||||
All cancers | 1353 | 37.0 | 25.4 | 18.0 | 19.7 | |
pTa G2 low | 109 | 41.3 | 11.9 | 23.9 | 22.9 | < 0.0001 |
pTa G2 high | 100 | 36.0 | 20.0 | 24.0 | 20.0 | |
pTaG3 | 144 | 18.8 | 27.8 | 24.3 | 29.2 | |
pT ≥ 2 G3 | 921 | 39.9 | 28.0 | 14.8 | 17.4 | |
pT ≥ 2 G3 sarcomatoid | 18 | 33.3 | 33.3 | 11.1 | 22.2 | |
pT ≥ 2 G3 small cell cancer | 18 | 66.7 | 33.3 | 0.0 | 0.0 | |
pN0 | 293 | 36.5 | 26.6 | 16.7 | 20.1 | 0.2540 |
pN+ | 170 | 27.7 | 29.4 | 18.2 | 24.7 |